<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/CINECAstyle.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-23T07:10:00Z</responseDate><request verb="GetRecord" identifier="oai:iris.unica.it:11584/265866" metadataPrefix="oai_dc">https://iris.unica.it/oai/request</request><GetRecord><record><header><identifier>oai:iris.unica.it:11584/265866</identifier><datestamp>2025-02-14T00:34:48Z</datestamp><setSpec>com_11584_207615</setSpec><setSpec>com_11584_111066</setSpec><setSpec>col_11584_265854</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Chitosan and PLGA microspheres as drug delivery system against pulmonary mycobacteria infections</dc:title>
<dc:creator>MANCA, MARIA LETIZIA</dc:creator>
<dc:subject>Chitosan</dc:subject>
<dc:subject>Cytotoxicity</dc:subject>
<dc:subject>Encapsulation</dc:subject>
<dc:subject> Stability</dc:subject>
<dc:subject>Microparticle</dc:subject>
<dc:subject>Mucoadhesion</dc:subject>
<dc:subject>Nebulization</dc:subject>
<dc:subject>PLGA</dc:subject>
<dc:subject>Rifampicin</dc:subject>
<dc:subject>Settore CHIM/09 - Farmaceutico Tecnologico Applicativo</dc:subject>
<dc:description>Various types of rifampicin (RIF)-loaded microparticles were compared for their stability during nebulization. Poly(lactide-co-glycolide) (PLGA), chitosan (CHT) and PLGA/CHT microparticles (MPs) were prepared by emulsion, precipitation or spray-drying techniques. MPs ability to be nebulized (NE%) as well as stability during freeze-drying or/and nebulization (NEED%), were evaluated after RIF extraction from MPs and determination by light spectroscopy. MP mean diameters and zeta-potential values were measured by dynamic light scattering, morphology was assessed by SEM, cytotoxicity by MTT method and mucoadhesive properties by mucin association. In all cases, freeze-drying prior to nebulization did not affect EE%, NE or NEED%. In CHT, MPs RIF encapsulation efficiency (EE%) decreased with increasing CHT concentration (viscosity) and CHT-MP NEED% was higher when the polymer was crosslinked by glutaraldehyde. PLGA MPs, exhibited both higher RIF EE% and also higher nebulization ability and NEED%, compared to CHT ones, but also higher cytotoxicity. However, when the two polymers were combined in the PLGA/CHT MPs, EE%, NE% and NEED% increased with increasing MP CHT-content. PLGA/CHT MPs with 0.50% or 0.75% CHT exhibited highest EE% for RIF and also best nebulization ability and stability, compared to all other MP formulations studied. Additionally they had good mucoadhesive properties and comparably low cytotoxicity.</dc:description>
<dc:date>2007-02-28</dc:date>
<dc:type>info:eu-repo/semantics/doctoralThesis</dc:type>
<dc:identifier>https://hdl.handle.net/11584/265866</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>numberofpages:134</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:publisher>Università degli Studi di Cagliari</dc:publisher>
<dc:rights>license:Non specificato</dc:rights>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>